NCT00348504View on ClinicalTrials.gov

Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

June 30, 2005

Conditions
Acute Heart Failure
Interventions
DRUG

levosimendan

DRUG

dobutamine

Trial Locations (1)

60064

Global Medical Information - Abbott, Abbott Park

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
collaborator

Orion Corporation, Orion Pharma

INDUSTRY

lead

Abbott

INDUSTRY

NCT00348504 - Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure. | Biotech Hunter | Biotech Hunter